Podcasts about mip

Dr. Luis Raez and Michael Reff share the newest update to the medically integrated dispensing pharmacy standards from NCODA and ASCO. They review updates to domain one, on key patient-centered quality standards on health equity and social determinants of health, drug access, patient safety, education, and adherence to maximize treatment outcomes and domain two, on key operational quality standards on logistics, care coordination, and waste prevention. We also cover the impact of these updated standards for clinicians, oncology practices, and people receiving oral anti-cancer medications. Read the complete standards, “Medically Integrated Dispensing Pharmacy: ASCO-NCODA Standards.” Transcript These standards, clinical tools, and resources are available on ASCO.org.  Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the JCO Oncology Practice. Brittany Harvey: Hello, and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts.  My name is Brittany Harvey, and today I'm interviewing Michael Reff from the Network of Collaborative Oncology Development and Advancement and Dr. Luis Raez from Memorial Cancer Institute and Florida Atlantic University, co-chairs on "Medically Integrated Dispensing Pharmacy: American Society of Clinical Oncology – Network of Collaborative Oncology Development and Advancement Association Standards Update." Thank you for being here, Michael and Dr. Raez. Dr. Luis Raez: Thanks for inviting us. Michael Reff: Thank you for having us. Brittany Harvey: Then, before we discuss these standards, I'd like to note that ASCO takes great care in the development of its standards and ensuring that the ASCO Conflict of Interest policy is followed for each guidance product. The disclosures of potential conflicts of interest for the expert panel, including Michael and Dr. Luis Raez who have joined us here today, are available online with the publication of the standards in JCO Oncology Practice, which is linked in the show notes. So then, to dive into the content here, Michael, I'd like to start with what prompted an update to these ASCO-NCODA standards and what is the scope of this update? Michael Reff: Thank you, Brittany. What led NCODA and ASCO to endeavor in this, and it started back in 2019 as the amount of oral anticancer medications became more and more prevalent in cancer treatment, we saw the need providing a blueprint for excellence in care for patients prescribed oral anticancer medications, specifically in the outpatient setting. And the update was driven by the rapid growth of these oral oncolytics starting back in the mid to late 2015 through 2019 or so, and then continued on into the 2020s where we are today. We saw the increase in the complexity of the management of these patients with these therapies basically outside the traditional clinical settings. And we wanted to make sure that with more cancer treatments that are taken at home than just at the clinic, like in the oral setting, new challenges had emerged around patient safety, access, adherence, and overall treatment success. The updates now address patient-centered and operational interventions designed to improve access, safety, quality, accountability, and outcomes of oral anticancer and other supportive care medications prescribed for the cancer patient. Dr. Luis Raez: As Mike said, these guidelines help improve patient care tremendously, but also help us a lot as an oncologist, you know, community oncologists that- now that we have opportunity to dispense these oral oncolytics, we need help to create our medical integrated pharmacies, and NCODA is providing here a way that, how to do this safely, efficaciously, good quality, you know? So that's why I think we always do everything for the patients, but also this helps a lot to the doctors. And there are a lot of what we call specialty pharmacies or medical integrated pharmacies now nationwide. Michael Reff: I'll build on what Dr. Raez had mentioned. This is the impetus. If you looked at the innovation that was coming from the pharmaceutical companies, many of it coming in the oral form for anticancer medications, and based on that, taking a look at the infrastructure that is in place in these practices, whether it's in the community or the IDN or health system settings, this amount of innovation that was coming needed to be addressed by taking a look at the medically integrated oncology team. And these standards address not just the pharmacy component, but also the whole continuum of care, starting with a medical oncologist or the hematologist, with the pharmacists, nurses, the pharmacy technicians, others that are involved in the care of the patient. And there were no standards involved. And when we approached ASCO back in 2018 to eventually publish the first version of these standards, the need was identified, and we worked collaboratively with ASCO to create the first set and then the revisions as we talked about. One thing to note regarding the revision plus the original standards, we had a cross-section of the care team on the committee, and we did that very purposefully. So, the ASCO-NCODA team curated a committee to help develop these original standards and the revision of these standards with medical oncologists both from community and health systems, pharmacists from both community and health systems, and also nurses. And we also included a patient that currently has and currently receives oral anticancer medication. And so NCODA and ASCO are very proud of the committee that we put together because of the experts in their field, but also extended the invitation to a current patient. And we embedded everybody's expertise in the curation of these standards. Brittany Harvey: Absolutely. I appreciate that background and context and how it's critical to improve patient care. And these standards really help oncologists, and we're looking across the continuum of care to provide optimal care for our patients. So then next, Dr. Raez, I'd like to review the key points of the revised standards for our listeners. So for Domain 1, what are the key patient-centered quality standards on health equity and social determinants of health, drug access, patient safety, education, and adherence to maximize treatment outcomes? Dr. Luis Raez: Yeah, this was a great effort, you know, at the multidisciplinary team. And as you can read in the standard, there were more than 240 publications reviewed; more than 55 of them are quoted here. And the standards are in two groups, as you said. With the group one, I'll briefly mention some of them. For example, SDOH, social determinants of health, is very important because as doctors, we prescribe, and sometimes patients don't get the medication, you know? And we prescribe assuming that 100% of the patients will get the medication. But something simple like the patient doesn't have insurance, the patient is underinsured. I have a patient that we didn't have an address to send the medication because he's homeless. Something that as a doctor you say, "Oh, oh my God, this is outside my realm," but it's not outside reality. So that's why, even if we don't think that this is part of our expertise dealing with social determinants of health, the fact that the patients have food insecurity, they don't have transportation, they don't have insurance, they don't have a caregiver, impact tremendously in the outcomes of the therapy. So that's why, basically, in this standard, we want to call attention that SDOH, social determinants of health, needs to be identified. There are in the literature countless examples of why this is important. For example, in the guidelines, we quote two or three examples of prostate cancer studies that, for example, we quote a study of 27,000 people with prostate cancer that were taking oral oncolytics, and how come the fact that the elderly, seniors, the fact that they have high prescription costs, and how all of this affected the adherence to the medication. And that's why it's important to identify the SDOH. And in other sections of the guidelines, we said how to address them, no? Another important thing in this domain is the cultural, you know, we need to be culturally sensitive and to take care of all of these social factors. For example, here in South Florida, we deal with the Haitian culture, Filipino culture, Latin culture, and American culture, and it's a blend, but it's not easy to go from one to the other. Another one is the fact that we have to include new technologies. A lot of patients, for example, we use EMR, EMR Epic, and now Epic has everything in the phone. The fact that we can have now the patient can see her prescription medication over the phone, the fact that they can use the phone to request from you a refill, and from your phone, you send the refill to the pharmacy, and you notify from your phone to the patient that the refill is sent, and the patient can check in his phone that the refill is ready. These things are amazing because that's why it's important that we incorporate these technologies to the patient care, and in this specific case, of dispensation of oral therapies, no? Another crucial point is education. You cannot be sending a patient a package of 300 pills without education. So that's why in our guidelines, mainly pharmacy, clinical pharmacies, or in some centers like mine, we have advanced practice providers, it's mandatory in our centers to have like a one hour of education before you send the prescription. So the patient is aware about side effects and contraindications, all of these things. They provide them also materials and also consent. You know, in the old times, you don't give chemo without a consent. Now, a lot of people say, "Oh, it's only a pill." There is a lot of benefits or side effects that can come from the pill, so you need to consent everybody, you know? So, another aspect is adherence. I already told about that, but we need to provide patients with a baseline assessment, no? So, you cannot send again the prescription and hope, "Oh, I'll figure it out what happened next month when the patient comes back." I tell you, the patient is homeless, where are you going to send it? If the patient is telling you, "I don't have insurance," what good is it for you to send a prescription? The patient will not get it. So that's why you need to do a baseline assessment of adherence. You need to do a calendar. You need to do electronic support, I mentioned already with the EMR and the phones. For example, my MIP, my specialty pharmacist, sends me a message in the EMR, "Dr. Raez, the insurance is not covering, the patient has a high copayment, we are going to delay the dispensation of the medication." So there needs to be a communication. Or sometimes there is a confusion with the insurance, and I cannot wait for the poor patient to call three, four weeks later, "Oh, I didn't get the medication," to know what happened, no? My MIP is very good. They send the clinical pharmacist a message, "Hey, you know, the insurance doesn't believe that the pill is adequate, or you need to provide more documentation. You need to prove the mutation, the genetic aberration." So if you provide us that, the insurance may approve. So that communication with the doctor is very important to improve adherence. And one important thing that we have in this one that we didn't have in the anterior is the tracking of outside medications. A lot of times you say, "Okay, the insurance allowed us to provide the medication it's 100% responsible." But then the insurance says, "Oh, no, no, don't worry. CVS will provide the medication." So it says, "Well, it's you know, it's not my responsibility. CVS will provide the medication, they have to take care." But we know that outside our specialty pharmacies or MIPs, the care is not very good. So that's why we are taking our ownership that, "Okay, the insurance said the patient will get the medication from some outside pharmacy." But our clinical pharmacists track that. What happened? Did the patient get it? The patient didn't get it. The copayment is still high. So even if you get the medication from somewhere else, if the copayment is high, we, our clinical pharmacists, help the patient to navigate and get the foundation or the copayment or finally the maker, the industry partner, provides the drug for free, but somebody needs to do the paperwork. And that's why this is very important. We cannot abort our responsibility because, "Oh, the insurance said somebody else will give it." I work for the public healthcare system, so my patients, some of them don't have insurance, they are underinsured. So we see these problems every day. And finally, the standards talk about the importance of safety, documentation, verification, monitoring, refills, you know, you need to keep track of refills. We already mentioned how important is the technology to facilitate the refills, and the quality. Brittany Harvey: Yes, thank you for touching on those highlights for Domain 1. It's important that all patients have access to care and these oral anticancer medications, and not only just access to care, but safe and effective care. It's really important, as you mentioned, Dr. Raez, to meet patients where they're at and incorporate technology. And I also want to note the coordination with external pharmacies that you mentioned in tracking outside medications as well. It's not only important for multidisciplinary care within the oncology practice itself, but also external to the oncology practice. That's why we put together this multidisciplinary panel to develop these standards. So then, expanding on that, Dr. Raez, for Domain 2, what are the key operational quality standards? Those on logistics, care coordination, and waste prevention. Dr. Luis Raez: Yeah, we have a lot of standards here, but maybe we can summarize in five or six points, no? For example, financial toxicity in cost and waste are very important because the patients, yeah, you put them on therapy, but as you can understand, if there is disease progression, the patient don't need the medications. And sometimes you get refills even if the patient has disease progression. If you do a dose reduction, the same problem. Or you discontinue medication and the patient keeps getting the drugs. So, you're talking about drugs that are between 20 and 30 thousand dollars per month. This is a lot of money. There are studies that we're quoting in the standards that the waste could be from 1 to 3 or 4 thousand per patient, no? Another aspect is dispensing. When you dispense the medication, this is not as easy as, "I'll ship to your house a bag of medications." You know, there needs to be a diagram, a decision tree. You need to train the staff to know what we're doing. There needs to be an auditing of the process. They need to be even packaging and shipping, you know? For example, I'm in Florida today and outside in summer it's going to be 95 degrees. So, everybody leaves the package outside your house, and sometimes you go the whole day until when you come at 6:00 p.m. There are medications that cannot be left outside there, you know? I don't know, it sounds like a joke, but I have a patient that the medication used to be stolen because people thought that that was something important, you know? And of course, it's important because it's a $20,000 medication. So, the poor patient, because he lives in an area that is not safe, has to come and pick up in person. All of these things sound very trivial, but that's real life that affects adherence. Another important thing is shortage. This is something that we just suffered two or three years ago, and we have to think about what happens in the next shortage. What happens if there's going to be a shortage? What do we do or how are we going to do that? Now we know it's something that is happening probably very soon again, and something that we have to consider. Another standard is the care coordination. You need to have probably, if it's possible, a coordinator. I know that for small practices it's very hard, but for big cancer centers, you should have a coordinator of this. I already mentioned before, the communication between the physicians and the doctors to coordinate the care, no? You need to write the prescription again, you need to provide more information, or to be notified, "Hey, you know, the patient is throwing up in the first week, you need to see the patient, please," no? So, this type of communication needs to exist so we can serve the patient better. It's also important, you know, we're improving quality and we're improving care. It's important to try to collect patient-reported outcomes. This is something that now we have the opportunity, if we do things well, to do it and show that we're providing a better care. The other thing is that we already mentioned SDOH in the other standard. In this standard, we mention mainly SDOH to partner. For example, we collect in my center SDOH, and I always get frustrated when the patient doesn't have transportation. But I didn't know that there are local institutions that provide free Uber rides, free Lyft rides. So that's why it's important to partner with these institutions. I have a local grocery chain that provides free food for the patients, and I didn't know that. It's important to be aware what the patient needs and what resources do you have to fulfill the SDOH. That's the part that we mention in here. So that's why, in summary, those are the six probably most important points here. I'll ask Mike for some comments. Michael Reff: Thank you, Dr. Raez. Brittany, to answer your question, and as was pointed out on logistics, care coordination, and prevention of waste, certainly that is an aspect that has changed in the revision that we're here to talk about. There's really two components to waste, and it's cost avoidance and then waste prevention. And as Dr. Raez mentioned several times, the importance of the medically integrated team and having the ability for that practice to fill that prescription internally and have robust documentation. Cost avoidance is a critical component that the medically integrated pharmacy, or the MIP, can help the total cost of care. And that is by preventing errant fills or waste that can occur by intervening in the care of the cancer patient, as we do every day. But when the practice has access to the medication and can fill that prescription in-house in the medically integrated pharmacy, that team, that care coordination that takes place, can prevent those errant fills or additional fills when there's dose reductions, there's holidays, there's things that happen in real time. And it's impossible for a mail-order pharmacy that's in another state that has lead times, when a prescription needs to be mailed 7 days or 10 days before the patient will run out of the medication, it's impossible for them to logistically coordinate that care like we can internally within the medically integrated pharmacy. So, we prevent waste and overall cost of care by cost avoidance and having that coordination or that continuity of care that we talk about. And we prevent waste from the mail-order pharmacies by taking that prescription internally and filling it, but also doing it in a way that's more sustainable and cost-effective for all stakeholders in the oncology ecosystem. Brittany Harvey: Absolutely. Thank you both for reviewing those key standards for Domain 2 and touching on the importance of distribution logistics and all the things that a medically integrated pharmacy needs to think through in getting oral anticancer agents to patients. Following that, Michael, we've touched on this a little bit earlier, but how will these updated standards impact clinicians and oncology practices? Michael Reff: Yes, and as Dr. Raez and I have discussed throughout this podcast, these additional standards are there to help support that continuity of care by educating the clinicians that are in the oral anticancer medication space to elevate their provision for these oral therapies. What I mean by that is the practice has to perform at a certain level in order for them to, as I call it, deserve the right to fill that prescription by having the processes and procedures in place. And these standards, these updated or revised standards, are the blueprint for better patient care and to help the practices execute on that journey of continuous improvement. Dr. Luis Raez: Yeah, I only want to add, we have practical examples in the guidelines. We quote a couple of studies that have been successful. And this year, for example, I am a lung cancer doctor, we are presenting in World Lung our standards of adherence to oral oncolytics for EGFR therapy, following the NCODA-ASCO standards. We're around 95% of adherence. We are a healthcare system that is public. We have people with no insurance and a lot of social determinants of health. We are trying to show that it's feasible, even in the most difficult circumstance, when you follow the standards, to be successful. Brittany Harvey: Definitely, these standards can help clinicians and oncology practices succeed in providing these medications. So then beyond that, and to wrap us up, Michael, what do these revised standards mean for patients who are receiving oral anticancer medications? Michael Reff: Yes, great point and question, Brittany, because we have covered the benefits to the clinicians and the practices themselves. But how is this going to support better patient care? And it does it in a whole host of ways. I'll cover just a few of them. What I'm about to share with you relates back to what we call at NCODA the "core claims." Like, what's the core claims of having a medically integrated pharmacy within the practice? And there are seven different core claims that we feel practices that are focused on the continuity of care can deliver better outcomes that are embedded in these standards. And it's talking about abandonment, adherence, access and affordability, speed to therapy or time to fill, as we call it, education, patient satisfaction, and cost avoidance that we covered earlier. So those are the core claims that a practice that follows these revised standards can help elevate. So, faster and more affordable access to the oral cancer medications; individualized support to address barriers like transportation, finance, language, or health literacy, and so on; clear, patient-friendly education; something that is near and dear to all clinicians' hearts, and of course, the patient that was on our panel or on our committee, to empower them to manage side effects and recognize when to seek help; and a stronger partnership with a care team, with regular follow-ups focused on their experience, challenges, and successes; and then, greater overall safety through proactive monitoring for medication errors or complications. So all of these aspects, or tenets, as I'll call them, are baked into these quality standards that are totally aligned with NCODA's core claims document that, again, talks about abandonment, adherence, access and affordability, speed to therapy, education, satisfaction for the patients, and also cost avoidance. Dr. Luis Raez: I only want to add and invite the community to adhere to these standards, to practice the standards. You will be providing the best patient care that we can nowadays. Brittany Harvey: Definitely. I think these standards are very important. And Michael, I thank you for touching on those key claims from NCODA. I think those, along with these updated standards, will improve outcomes for patients everywhere. So I want to thank you both so much for your work to update these standards and all the time you put into it. And thank you for your time today too, Michael and Dr. Raez. Michael Reff: I'd like to thank not only the committee, my esteemed committee that helped support the standards and the revision. Many of the original healthcare providers and patient that were on the first go of the standards were part of the second standards. We revised it, of course, and we got additional support from the new committee. And certainly ASCO and their partnership and collaboration with NCODA has been tremendous. And we look forward to the oncology community at large adopting these standards, again, to work together, we do become stronger, and it will improve cancer care for patients receiving oral anticancer medications. So thank you, Brittany. Dr. Luis Raez: I only want to say the same thing. Actually, there is probably more people in NCODA that is not in the publication that has helped. Same in ASCO. Also, we want to give thanks to Dr. Stephen Grubbs, our leader in quality. He's retiring. We're going to miss him, but he has been a key collaborator with Mike organizing these standards for the last five or six years. So, looking forward to these standards in practice. Brittany Harvey: Absolutely. A big thank you to the entire panel and everyone who contributed to this, and NCODA as well. And then finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the complete standards, go to www.asco.org/standards. I also encourage you to check out the companion episode on these standards on the PQI podcast by NCODA, which you can find on Apple Podcasts and Spotify. You can also find many of our standards and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

SD307 - Prescrição de autocuidado como diferencial competitivo para o médico. Neste episódio, Dr. Lorenzo Tomé convida Cibele Costa Zanotta, Presidente Executiva da Acessa, para um papo sobre autocuidado em saúde e os benefícios quando ele é bem empregado como sustentabilidade do sistema e economia em horas de paciente; a necessidade de levar informação pautada em ciência para o paciente se autocuidar e o diferencial competitivo do médico que oferece esse tipo de serviço. A Acessa fornece orientação ética aos profissionais da saúde e ao consumidor com a finalidade de garantir a correta aplicação do conceito de medicamento isento de prescrição médica e seu uso responsável, realizando várias ações. Vem aí a 3ª Imersão da Escola de Negócios Médicos. Entenda sobre os 5 Pilares de um Negócio. Saiba mais AQUI! Participe das comunidades SD Conecta. Acesse AQUI! Baixe nosso app: Android ou IOS O Background da Cibele Cibele é advogada de formação e já trabalhou em escritório, na indústria até ir atuar na Acessa pelo propósito de levar letramento para a sociedade e o Governo sobre o autocuidado em saúde. Assista este episódio também em vídeo no YouTube no nosso canal Saúde Digital Podcast: AQUI! Acesse os Episódios Anteriores! SD306 - 5 Pitfalls que corroem o lucro do seu negócio médico SD305 - Case de Sucesso: Estratégias da Human Clinic para se Destacar no Mercado SD304 - Do Ads ao Equity: A Estratégia que une Marketing e Investimento em Startups Music: Star - Declan DP "Music © Copyright Declan DP 2018 - Present. https://license.declandp.info | License ID: DDP1590665"

Als die britische Krankenschwester Florence Nightingale am 4. November 1854 im Lazarett in Scutari ankommt, sterben im Schnitt vier von zehn Patienten. Mithilfe von statistischen Analysen und deren visueller Aufbereitung kann Nightingale die Sterblichkeitsrate unter den verletzten und kranken Soldaten drastisch senken. Den Artikel von Manon Bischoff aus der Reihe „Die fabelhafte Welt der Mathematik“ über Florence Nightingale und die Datenvisualisierung könnt ihr hier lesen. Ein Archiv der schriftlichen Arbeiten von Florence Nightingale findet ihr hier. Und den Nachruf über Florence Nightingale, der am 15. August 1910 in der Times erschienen ist, lest ihr hier nach. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:01) Einleitung (00:03:23) Der frühe Wunsch nach Unabhängigkeit (00:06:34) Alles für den Traumjob Krankenschwester (00:10:43) Als Krankenpflegerin in den Krimkrieg (00:16:36) Nightingales Engagement im Lazarett (00:21:47) Visualisierung von Daten (00:24:59) Die Macht der Statistik (00:30:13) Manipulative Diagramme (00:33:53) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-florence-nightingale

In this episode of Go Gaddis Real Estate Radio, Cleve Gaddis unpacks two essential pieces of the mortgage puzzle: PMI (Private Mortgage Insurance) and MIP (Mortgage Insurance Premium). If you're planning to buy a home with less than 20% down—or using an FHA loan—this is a must-listen segment.

Nesta edição do Agrolink News, abordamos um dos principais desafios fitossanitários da cultura da soja: o manejo eficaz de pragas sugadoras, como percevejos, mosca-branca e cigarrinha. Essas pragas têm potencial para causar prejuízos significativos à produtividade e à qualidade dos grãos, exigindo ações integradas e baseadas em boas práticas agrícolas.Para aprofundar o tema, conversamos com exclusividade com o Luiz Henrique Marcandalli, responsável pelo Marketing da Rainbow Agro Brasil, destaque internacional no setor de proteção de cultivos. Durante o bate papo, são exploradas alternativas inovadoras com ação duradoura, táticas de controle integrado (MIP) e iniciativas sustentáveis voltadas à harmonização entre desempenho no campo e compromisso ecológico.O episódio é voltado a profissionais do setor e produtores que buscam informações qualificadas para enfrentar os desafios da próxima safra com planejamento e eficiência.

Als der französische Mathematiker Cédric Villani 2010 die Fields-Medaille gewinnt, ist das der Höhepunkt seiner Karriere als mathematischer Forscher — doch sie markiert zugleich den Startpunkt einer neuen Karriere als wissenschaftlicher Kommunikator und Politiker. Den Disney-Kurzfilm „Donald in Mathmagic Land“ könnt ihr hier anschauen. Manon und Demian bei „Behind Science“ über die Geschichte der Zahl Null könnt ihr hier anhören. Demian bei „Behind Science“ über Mathe im Café findet ihr hier. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:02) Einleitung (00:03:34) Wozu Wissenschaftskommunikation? (00:06:08) Villani: Mathe-Liebe auf den ersten Blick (00:09:53) Eine steile Forschungskarriere (00:14:20) Die Folgen der Fields-Medaille (00:17:14) Villani zwischen Wissenschaft und Politik (00:20:45) Die Komplexität der Boltzmann-Gleichung (00:24:56) Physikalische Systeme und ihre Zeitrichtung (00:30:36) Die zunehmende Komplexität der Welt (00:37:46) Manon und Demian über Forschung & Wissenschaftskommunikation (00:40:20) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-cedric-villani

Als der französische Mathematiker Cédric Villani 2010 die Fields-Medaille gewinnt, ist das der Höhepunkt seiner Karriere als mathematischer Forscher — doch sie markiert zugleich den Startpunkt einer neuen Karriere als wissenschaftlicher Kommunikator und Politiker. Den Disney-Kurzfilm „Donald in Mathmagic Land“ könnt ihr hier anschauen. Manon und Demian bei „Behind Science“ über die Geschichte der Zahl Null könnt ihr hier anhören. Demian bei „Behind Science“ über Mathe im Café findet ihr hier. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:02) Einleitung (00:03:34) Wozu Wissenschaftskommunikation? (00:06:08) Villani: Mathe-Liebe auf den ersten Blick (00:09:53) Eine steile Forschungskarriere (00:14:20) Die Folgen der Fields-Medaille (00:17:14) Villani zwischen Wissenschaft und Politik (00:20:45) Die Komplexität der Boltzmann-Gleichung (00:24:56) Physikalische Systeme und ihre Zeitrichtung (00:30:36) Die zunehmende Komplexität der Welt (00:37:46) Manon und Demian über Forschung & Wissenschaftskommunikation (00:40:20) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-cedric-villani

Als der französische Mathematiker Cédric Villani 2010 die Fields-Medaille gewinnt, ist das der Höhepunkt seiner Karriere als mathematischer Forscher — doch sie markiert zugleich den Startpunkt einer neuen Karriere als wissenschaftlicher Kommunikator und Politiker. Den Disney-Kurzfilm „Donald in Mathmagic Land“ könnt ihr hier anschauen. Manon und Demian bei „Behind Science“ über die Geschichte der Zahl Null könnt ihr hier anhören. Demian bei „Behind Science“ über Mathe im Café findet ihr hier. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:02) Einleitung (00:03:34) Wozu Wissenschaftskommunikation? (00:06:08) Villani: Mathe-Liebe auf den ersten Blick (00:09:53) Eine steile Forschungskarriere (00:14:20) Die Folgen der Fields-Medaille (00:17:14) Villani zwischen Wissenschaft und Politik (00:20:45) Die Komplexität der Boltzmann-Gleichung (00:24:56) Physikalische Systeme und ihre Zeitrichtung (00:30:36) Die zunehmende Komplexität der Welt (00:37:46) Manon und Demian über Forschung & Wissenschaftskommunikation (00:40:20) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-cedric-villani

It's the second round of the NBA Playoffs and Bogues & Pro are fired up! The Grizzlies and Spurs make historic coaching moves, Haliburton's dad confronts Giannis courtside, and Giannis trade rumours are heating up. Game 7 disasters, playoff breakdowns, and what's next for Harden and Simmons? Knicks, Timberwolves, and Celtics all impress, while Warriors vs Rockets was a gritty grind. Plus, second-round previews, Dyson Daniels wins MIP, and we ask—Useful or Useless? In the NBL, controversy brews as Larry Kestelman's travel agency deal raises integrity questions. Another huge episode packed with takes, laughs, and deep hoops analysis. 00:00:31 Intro 00:01:12 
Latest NBA News 00:14:16 NBA Awards 00:15:57 Playoffs Chat 01:24:54 Useful or Useless 01:33:07 Fact or Fake News 01:37:09:22 Latest NBL News © 2025 AMB Media

In this week's episode we spoke about round 1 of the NBA playoffs series including Denver knocking out the Clippers, Lakers going down and our round 2 predictions, we then spoke about Dyson Daniels well deserved MIP award, Pop retiring, Dads on the court, true/false and then finished off with another classic pack! Please make sure you LIKE and SUBSCRIBE! 0:00 Kick Off 0:44 Throwback Jerseys for the week- Vlade Divac and Aaron Nesmith 7:06 Card of the week- Tracy McGrady- Fleer 2005 Relic/Auto Card 10:24 Quick hits- Dyson Daniels wins MIP and Gregg Popovich retires 14:55 NBA- Playoff round 1 update including the Nuggets big win vs Clippers, Lakers and Pistons season ending loses and thoughts on the upcoming game 7 game between Golden State and Hoston, we also gave out round 2 predictions! 32:38 True/False- NBA 37:18 Classic packs is back!- Fleer 1991-92 43:54 Outro Please sit back and enjoy and spread the word about Throwback Hoops. Much love Rob and Woody V We will back later next week with a special guest!

See Red UK is back with a bang as we break down and grade every Chicago Bulls player from the 2024-25 season! From standout performances to underwhelming disappointments, we're handing out our official season awards and diving into who showed up—and who didn't. Whether you're a die-hard Bulls fan or just love NBA analysis, this one's for you. In this video: Grading Chicago Bulls roster player-by-player 2024/25 Chicago Bulls MVP, MIP, Unsung Hero Honest takes, UK perspective, and fan reactions What the Bulls need to do next Join the See Red UK movement – the British and Irish voice of Bulls Nation Don't forget to like, comment, and subscribe for more Chicago Bulls content! #ChicagoBulls #SeeRedUK #NBA2025 #BullsNation #SeasonGrades #NBAAwards #UKBullsFans #BullsAnalysis #CobyWhite #MatasBuzelis #JoshGiddey Learn more about your ad choices. Visit megaphone.fm/adchoices

Srinivasa Ramanujan hat einen eigenen Zugang zur Mathematik. Weil er Autodidakt ist und die konventionellen Regeln des Fachs nicht kennt, folgt er seiner Intuition — und schreibt damit Geschichte. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:06) Einleitung (00:02:59) Indiens Mathematik-Tradition (00:04:46) Ramanujans Jugend und mathematische Prägung (00:09:59) Ramanujans Karriere: Intuition statt Konvention (00:16:38) Einmal England und zurück (00:19:20) Die „Taxicab-Number“: 1729 (00:25:41) Die Formel und der Zufallsfund (00:29:38) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-srinivasa-ramanujan

Srinivasa Ramanujan hat einen eigenen Zugang zur Mathematik. Weil er Autodidakt ist und die konventionellen Regeln des Fachs nicht kennt, folgt er seiner Intuition — und schreibt damit Geschichte. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:06) Einleitung (00:02:59) Indiens Mathematik-Tradition (00:04:46) Ramanujans Jugend und mathematische Prägung (00:09:59) Ramanujans Karriere: Intuition statt Konvention (00:16:38) Einmal England und zurück (00:19:20) Die „Taxicab-Number“: 1729 (00:25:41) Die Formel und der Zufallsfund (00:29:38) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-srinivasa-ramanujan

Srinivasa Ramanujan hat einen eigenen Zugang zur Mathematik. Weil er Autodidakt ist und die konventionellen Regeln des Fachs nicht kennt, folgt er seiner Intuition — und schreibt damit Geschichte. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:06) Einleitung (00:02:59) Indiens Mathematik-Tradition (00:04:46) Ramanujans Jugend und mathematische Prägung (00:09:59) Ramanujans Karriere: Intuition statt Konvention (00:16:38) Einmal England und zurück (00:19:20) Die „Taxicab-Number“: 1729 (00:25:41) Die Formel und der Zufallsfund (00:29:38) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-srinivasa-ramanujan

Peu de surprises dans les finalistes des trophées de fin de saison : si Shai Gilgeous-Alexander devrait remporté le titre de MVP, il y a revanche plus d'incertitudes pour le trophée de MIP ou de Défenseur de l'Année.Avec Jacques Monclar et Nicolas Sarnak.Jacques Monclar, Rémi Reverchon, Mary Patrux, Xavier Vaution, Fred Weis et Chris Singleton décryptent l'actualité de la NBA dans le Podcast NBA Extra. En complément de l'émission lancée en 2012, beIN SPORTS a créé, avec ce podcast, un nouveau format pour revenir en profondeur sur la ligue nord-américaine de basketball. Chaque semaine, les membres de l'émission débattent autour de trois thèmes majeurs, qui font l'actualité de la NBA.

As bispecific therapies become more available in the outpatient setting, community oncology practices are adapting to support safe and effective treatment.In this CE episode, we sit down with Nick Bouchard, PharmD, Director of Pharmacy Services at Hematology Oncology Associates of Central New York (HOACNY), to explore how his team built a successful outpatient bispecific therapy program from the ground up.Nick offers real-world insight into how his community oncology practice is proactively managing side effects like CRS and ICANS, improving patient experiences, and reducing hospital admissions. From navigating flexible dosing schedules to coordinating across the care team, this episode highlights the strategies that are making a meaningful difference in patient-centered care.

John and Bill return to CBSSN to break down Bill's entire real NBA awards ballot. He has to turn it in right after the show and we walk through each award and make a decision... (0:00) Intro (2:08) MVP (12:15) All-NBA Teams (22:29) DPOY (26:00) All Defense (32:29) MIP (35:06) 6MOY (36:00) ROY (37:45) COTY (40:40) 7/8 Preview: Magic/Hawks (41:50) 7/8 Preview: Warriors/Grizzlies

The CHGO Bulls crew hand out awards to the Chicago Bulls squad. Everything from MVP, Best Newcomer to Most Disappointing Player and Favorite Moment Of The Year, we break it all down and award the good, bad and awesome that happened this season. Also, We give our selections for who will win the major NBA Awards. MVP, DPOY, MIP , COY and more.

Der letzte Tag der regulären Saison steht an und welch besseres Timing könnte es geben für unsere traditionelle Awardshow. Andreas, Chris und Tim (und Leo im Geiste eines PDF) haben sich zusammengefunden, um im ersten Teil der Show über Rookies, Executives, Clutch Player und MIP zu sprechen, natürlich nicht ganz ohne die eine oder andere Reibung  Viel Spaß!https://linktr.ee/airballpodcast?fbclid=PAAaY_uTZX2oLNnqxMI2tGsVZ4kWKgvX-pptvZCa9tVrqE2_FCH67dshC_J5MMusik von Ju von Dölzschen, checkt ihr hier:https://www.99funken.de/lets-play-3x3https://instagram.com/ju.von.doelzschen?utm_medium=copy_link

The nerds give out their final award picks & All-NBA selections, breaking down the Shai Gilgeous-Alexander vs. Nikola Jokic MVP debate for the last time, arguing Evan Mobley vs. Draymond Green for DPOY, and discussing whether Steph Curry or Anthony Edwards deserves the final First-Team All-NBA spot. Timestamps 00:00:23 - MVP 00:15:42 - DPOY 00:23:24 - ROY 00:30:39 - COY 00:36:53 - MIP 00:45:58 - 6MOY 00:54:30 - All-NBA 1st Team 00:58:56 - All-NBA 2nd Team 01:02:35 - All-NBA 3rd Team 01:08:18 - All-Defense 1st Team 01:16:20 - All-Defense 2nd Team 01:24:08 - All-Rookie 1st Team 01:28:03 - All-Rookie 2nd Team #VolumeSee omnystudio.com/listener for privacy information.

Pierre de Fermat ist vor allem berühmt für das Mathe-Rätsel, das er der Welt 1641 in einer Randnotiz aufgibt. Daneben gerät der gelernte Jurist in Konfikt mit dem namhaften Philosophen René Descartes — der Mathematik zuliebe. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:00) Einleitung (00:04:48) Das Jahrhundert der Mathematik (00:05:45) Fermat zwischen Jura und Mathematik (00:08:36) Wie Descartes die Wissenschaft prägt (00:10:37) Der Konflikt mit Descartes (00:17:57) Der Satz von Fermat (und Pythagoras) (00:22:53) Fermats berühmte Randnotiz (00:24:36) Der Widerspruchsbeweis (00:26:39) Wiles‘ Beweis & der Simpsons-Gag (00:30:46) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-pierre-de-fermat

Pierre de Fermat ist vor allem berühmt für das Mathe-Rätsel, das er der Welt 1641 in einer Randnotiz aufgibt. Daneben gerät der gelernte Jurist in Konfikt mit dem namhaften Philosophen René Descartes — der Mathematik zuliebe. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:00) Einleitung (00:04:48) Das Jahrhundert der Mathematik (00:05:45) Fermat zwischen Jura und Mathematik (00:08:36) Wie Descartes die Wissenschaft prägt (00:10:37) Der Konflikt mit Descartes (00:17:57) Der Satz von Fermat (und Pythagoras) (00:22:53) Fermats berühmte Randnotiz (00:24:36) Der Widerspruchsbeweis (00:26:39) Wiles‘ Beweis & der Simpsons-Gag (00:30:46) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-pierre-de-fermat

Email the show your award's picks or cases at Hoopstemple@gmail.comAaron, Dylan and Nate cast their unofficial ballots for MVP, DPOY, MIP, ROTY, COTY, All-NBA 1st, 2nd, & 3rd teams, All-Rookie 1st & 2nd team, and All-Defensive 1st & 2nd teams Tiktok ChannelsAaron @PossiblechairsDylan @pres.bball.conversationsNate @Nate_Hoopstemple⁠⁠⁠https://linktr.ee/Temple_EAM

1. FHA Loan (Federal Housing Administration Loan)Credit Score Requirement: As low as 500 (with 10% down) or 580+ (with 3.5% down).Best For: First-time homebuyers and those with lower credit.Pros: Low down payment, flexible credit requirements.Cons: Requires mortgage insurance premiums (MIP).2. VA Loan (Veterans Affairs Loan) (For eligible military members & veterans)Credit Score Requirement: No official minimum, but lenders may require 580-620+.Best For: Veterans, active-duty military, and qualifying spouses.Pros: No down payment, no private mortgage insurance (PMI), competitive interest rates.Cons: VA funding fee required.3. USDA Loan (United States Department of Agriculture Loan)Credit Score Requirement: 580+ preferred, some lenders may allow lower.Best For: Buyers in rural or suburban areas with low-to-moderate income.Pros: No down payment, lower mortgage insurance costs.Cons: Must meet income and location eligibility.4. Subprime or Non-Qualified Mortgage (Non-QM Loans)Credit Score Requirement: 500-620+ (varies by lender).Best For: Borrowers who don't qualify for conventional loans.Pros: Flexible underwriting standards, alternative income verification.Cons: Higher interest rates and fees.5. Conventional Loan (With a Non-Traditional Lender)Credit Score Requirement: Typically 620+, but some lenders allow lower with compensating factors.Best For: Borrowers with a higher down payment or strong income history.Pros: No upfront mortgage insurance if you put 20% down.Cons: Stricter credit requirements, PMI required if

Nekias Duncan and Steve Jones Jr. bounce around the NBA with observations, catch up on the latest news, then answer a pair of questions from the Dunker Spot mailbag.If you ever have NBA or WNBA questions, email us at dunkerspot@yahoo.com.If you'd like to join our Dunker Spot Playoff watch parties -- they're free, and easy to sign up for -- you can do so here: https://www.playback.tv/thedunkerspotTIME STAMPS0:52 -- Grizzlies fire Taylor Jenkins 25:14 -- A quick Raptors/Wizards salute32:13 -- OG Anunoby's recent run34:11 -- Is the MIP in LA?36:33 -- The Heat can't miss41:46 -- Knicks figuring things out43:10 -- (W)NBA News (Jordan Goodwin, LaMelo Ball, Gary Payton II, Breanna Stewart)45:48 -- Mailbag, starting with a fandom question58:11 -- Why are there so many "unders" in college?1:03:32 -- Comparing past rookie seasons to this year's ROY race1:10:43 -- A name-branching update1:13:51 -- Free ThrowsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Sports Reporter Travis Hicks joins in on The Run! End of the season awards in the NBA will be announced in 3-4 weeks as the regular season comes to an end. Who's your expected award winners for MVP, MIP, DPOY, Coach of the Year, and more? -- Voicemail call in: (219) 413-9405 Instagram: @TheRunPodcast Facebook: PodcastTheRun YouTube: The Run with Manny Wilson TheRunUSA.com -- Use the Promo Code: THERUNPODCAST for $20 OFF your first ticket purchase with SeatGeek. https://seatgeek.onelink.me/RrnK/teamseatgeek

Sports Reporter Travis Hicks joins in to discuss the impact of Pistons brawl with the Minnesota Timberwolves. The Pistons have tripled the amount of wins from last season and continue to show NBA fans they mean business. Isaiah Steward is a symbol of toughness, but what else will it take for the league to take notice of the Talent in Detroit??? End of the season awards in the NBA will be announced in 3-4 weeks as the regular season comes to an end. Who's your expected award winners for MVP, MIP, DPOY, Coach of the Year, and more? -- Voicemail call in: (219) 413-9405 Instagram: @TheRunPodcast Facebook: PodcastTheRun YouTube: The Run with Manny Wilson TheRunUSA.com -- Use the Promo Code: THERUNPODCAST for $20 OFF your first ticket purchase with SeatGeek. https://seatgeek.onelink.me/RrnK/teamseatgeek

Am 11. November 2013 postet eine Userin in einem Mathe-Forum ein Integral. Es scheint unlösbar. Doch dann kommt Cleo. Cleo hat die Lösung sofort parat — aber macht ein Geheimnis aus dem Lösungsweg und aus der eigenen Identität. Ein Katz-und-Maus-Spiel beginnt, das bis 2025 andauern wird … Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:00) Einleitung (00:02:14) Mathe-Foren und ihre Regeln (00:05:56) Cleo und das anstößige Integral (00:11:49) Der integrale Ragebait (00:17:36) Showdown: Wer ist Cleo? (00:20:30) How to Integralrechnung? (00:28:50) Verdachtsfall „Cleo“ (00:32:14) Der Professor und sein Alter Ego (00:35:14) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-cleo

Am 11. November 2013 postet eine Userin in einem Mathe-Forum ein Integral. Es scheint unlösbar. Doch dann kommt Cleo. Cleo hat die Lösung sofort parat — aber macht ein Geheimnis aus dem Lösungsweg und aus der eigenen Identität. Ein Katz-und-Maus-Spiel beginnt, das bis 2025 andauern wird … Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:00) Einleitung (00:02:14) Mathe-Foren und ihre Regeln (00:05:56) Cleo und das anstößige Integral (00:11:49) Der integrale Ragebait (00:17:36) Showdown: Wer ist Cleo? (00:20:30) How to Integralrechnung? (00:28:50) Verdachtsfall „Cleo“ (00:32:12) Der Professor und sein Alter Ego (00:35:11) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-cleo

Nekias Duncan and Steve Jones Jr. bounce around the NBA with observations and catch up on the latest news. Then, the guys put a bow on the inaugural season of Unrivaled before answering questions from the Dunker Spot mailbag.If you ever have NBA or WNBA questions, email us at dunkerspot@yahoo.com.If you'd like to join our Dunker Spot Playoff watch parties -- they're free, and easy to sign up for -- you can do so here: https://www.playback.tv/thedunkerspotTIME STAMPS1:20 -- Nekias' observations (GSW, HOU, MIP race)29:03 -- Steve's observations (CLE, fun of March hoops)40:43 -- NBA news (Paul George, De'Aaron Fox, Trey Murphy III)42:48 -- Liberty trade for Natasha Cloud51:28 -- Unrivaled Wrap-up01:14:44 -- Mailbag, starting with a question on player value 01:20:12 -- The impact and future of WNBA games in non-WNBA cities01:23:36 -- Great defenders on not-great defenses01:37:09 -- Love for the Pistons & a (defensive) 6th Man question01:42:31 -- How to build around Zion WilliamsonSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

John and Bill return to CBS Sports Network with a break down of all the NBA's biggest awards a month out from the end of the regular season. Joker or SGA for MVP? They also tell you who will win COY, DPOY, ROY, 6MOY and MORE! (0:00) Intro (1:02) MVP (12:05) DPOY (18:08) ROY (21:30) COY (26:23) 6MOY (31:25) MIP (37:30) CPOY (39:08) Team of the Night

Dem britischen Mathematiker Alan Turing gelingt 1940 ein großer Coup: Endlich funktioniert die von ihm konzipierte „Bombe“, die den Nazis das Handwerk legen soll — und wird. Allerdings nicht durch ihre Sprengkraft im wörtlichen Sinne. (00:03:02) Kryptografie im Zweiten Weltkrieg (00:09:08) Alan Turings Schulzeit (00:13:46) Turings erste Durchbrüche (00:15:22) Der Ruf nach Bletchley Park (00:18:07) Die Besonderheiten der Enigma (00:21:36) Die Turing-Bombe (00:25:38) Die Suche nach mathematischen Mustern (00:29:38) Die Macht der Morphogene (00:36:22) Verfolgter Kriegsheld (00:41:37) Fazit & Verabschiedung Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. 00:00:00.000 Einleitung 00:03:02.521 Kryptografie im Zweiten Weltkrieg 00:09:08.066 Alan Turings Schulzeit 00:13:46.190 Turings erste Durchbrüche 00:15:22.258 Der Ruf nach Bletchley Park 00:18:07.676 Die Besonderheiten der Enigma 00:21:36.739 Die Turing-Bombe 00:25:38.105 Die Suche nach mathematischen Mustern 00:29:38.467 Die Macht der Morphogene 00:36:22.671 Verfolgter Kriegsheld 00:41:37.287 Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-alan-turing

Dem britischen Mathematiker Alan Turing gelingt 1940 ein großer Coup: Endlich funktioniert die von ihm konzipierte „Bombe“, die den Nazis das Handwerk legen soll — und wird. Allerdings nicht durch ihre Sprengkraft im wörtlichen Sinne. (00:03:02) Kryptografie im Zweiten Weltkrieg (00:09:08) Alan Turings Schulzeit (00:13:46) Turings erste Durchbrüche (00:15:22) Der Ruf nach Bletchley Park (00:18:07) Die Besonderheiten der Enigma (00:21:36) Die Turing-Bombe (00:25:38) Die Suche nach mathematischen Mustern (00:29:38) Die Macht der Morphogene (00:36:22) Verfolgter Kriegsheld (00:41:37) Fazit & Verabschiedung Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. 00:00:00.000 Einleitung 00:03:02.521 Kryptografie im Zweiten Weltkrieg 00:09:08.066 Alan Turings Schulzeit 00:13:46.190 Turings erste Durchbrüche 00:15:22.258 Der Ruf nach Bletchley Park 00:18:07.676 Die Besonderheiten der Enigma 00:21:36.739 Die Turing-Bombe 00:25:38.105 Die Suche nach mathematischen Mustern 00:29:38.467 Die Macht der Morphogene 00:36:22.671 Verfolgter Kriegsheld 00:41:37.287 Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-alan-turing

On this edition of The Big Number, Tom Haberstroh and Dan Devine take a look at every single front-runner for each of the NBA Awards: MVP, Most Improved Player, 6th Man of the Year, Coach of the Year and Defensive Player of the Year. Will the current favorites hang on for the next month? Tom and Dan break down SGA's chances of winning his 1st MVP, and whether LeBron James has a true, viable path to chasing him down (in LeBron chasedown fashion). Evan Mobley is the current DPOY favorite, but Tom explains why he "hates" that. Could Evan's head coach Kenny Atkinson be caught by JB Bickerstaff? Cade Cunningham leads MIP as the Pistons dream season continues, but should former #1 overall picks even be eligible for that award? And the nominees that could catch Payton Pritchard for 6MOY. Plus the guys weigh in on the devastating Kyrie Irving news as it pertains to his looming contract situation, and go in hard on Mavericks GM Nico Harrison.(1:40) - Big Number: SGA or Jokic for MVP? (or LeBron?)(18:55) - Little Number: Defensive Player of the Year(25:20) - Little Number: Coach of the Year(29:50) - Little Number: 6th Man of the Year(34:35) - Most Improved Player(42:55) - Scoreboard update: Tom ties it(44:50) - What Kyrie's injury means for Dallas'

BRONCO FOCUS EVERY MONDAY-FRIDAY AT 3:45 P.M.: Bob Behler, the voice of Boise State athletics, joins Prater and Mallory to share why running back Sire Gaines is his No. 1 Most Important Player on the Broncos' football roster. Prater and Mallory have Gaines listed at No. 8 in their 15-player MIP series.See omnystudio.com/listener for privacy information.

BRONCO FOCUS EVERY MONDAY-FRIDAY AT 3:45 P.M.: Bob Behler, the voice of Boise State athletics, joins Prater and Mallory to share why running back Sire Gaines is his No. 1 Most Important Player on the Broncos' football roster. Prater and Mallory have Gaines listed at No. 8 in their 15-player MIP series.

BRONCO FOCUS EVERY MONDAY-FRIDAY AT 3:45 P.M.: Bob Behler, the voice of Boise State athletics, joins Prater and Mallory to share why running back Sire Gaines is his No. 1 Most Important Player on the Broncos' football roster. Prater and Mallory have Gaines listed at No. 8 in their 15-player MIP series.See omnystudio.com/listener for privacy information.

Tom Haberstroh and Dan Devine have stumbled across undeniable evidence: the 2024-25 Cleveland Cavaliers are the best team in franchise history. Yes, better than the 2016 title-winning team (sorry, LeBron!) by EVERY statistical measure. The Big Number this week focuses on the Cavs' margin of victory, which has now encroached "all-time great" status. The ascent of Evan Mobley, the MIP case for Ty Jerome, how Kenny Atkinson and Koby Altman have been right with every decision, the addition of De'Andre Hunter, how this has been the best individual seasons for both Donovan Mitchell and Darius Garland... and how Max Strus is playing the Cavs' "Steph Curry" role (don't worry: Tom and Dan will explain)! The Cavs are absurdly good and this episode will tell you what has been "The Diff."Plus — the Los Angeles Lakers are somehow BETTER defensively with Luka Doncic than they were with Anthony Davis. How is that possible?? Tom and Dan have you covered on every angle from LeBron past to LeBron present on this must-watch installment of The Big Number.(1:00) - The Big Diff: Cavs' historic point differential(13:35) - Cavs' insane offensive rating+(17:35) - Cavs have 20% of the top players in win share per 48 min(22:15) - Evan Mobley's impact on Cavs offense(28:35) - 10 Cavs players averaging 19+ minutes per game(34:30) - Over/under scoreboard update(35:10) - Reacting to Luka Doncic against the Mavericks

Im 15. Jahrhundert ist Maria Stuart Königin von Schottland — aber sie will mehr. Sie ist auf den englischen Thron aus, legt sich mit der Königin Elisabeth I. an, spinnt Intrigen. Schließlich wird sie zum Opfer ihrer eigenen Verschwörungen: Menschliche und kryptografische Fehler kosten sie das Leben. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:02) Einleitung (00:02:34) Drei Königreiche für ein Drama (00:05:46) Die junge Königin von Schottland und Frankreich (00:10:31) Katholizismus vs. Protestantismus (00:13:10) Das Schicksal von Elisabeth I. (00:16:28) Kabale und Liebe (00:19:42) Maria Stuart in englischer Gefangenschaft (00:23:10) Eine kurze Geschichte der Kryptografie (00:30:01) Verschlüsselte Verschwörung (00:32:11) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/politik/geschichten-aus-der-mathematik-maria-stuart

Today, Clark recommends a simple measure we can take to help protect our financial accounts, and those of our aging loved ones, from fraud. Also - many are looking to book their summer travel, and the airlines are raising prices. Clark shares strategies to bend that price curve in your favor.  Trusted Contacts: Segment 1 Ask Clark: Segment 2 Navigating Airfares: Segment 3 Ask Clark: Segment 4 Mentioned on the show: Why You Should Name a Trusted Contact How to protect yourself against financial exploitation - Vanguard How To Cancel & Get Rid of PMI Earlier What's the difference between PMI and MIP? National Association of Enrolled Agents Best 529 College Savings Plans By State Clark Howard's Airfare Price Predictions for 2025 Follow Clark Howard's #1 Rule To Travel Cheap NYTimes: Prices: A Mixed Outlook on Flights, Hotels and Cruises Coming to a Tiny Airport Near You: New Airlines Booking a Cruise? Here Are 5 Ways To Do It for Less Tipping on a Cruise: Your Complete Big-Ship Tip Guide InsureMyTrip Review: Why We Like It and How to Use It Clark.com resources Episode transcripts Community.Clark.com / Ask Clark Clark.com daily money newsletter Consumer Action Center Free Helpline: 636-492-5275 Learn more about your ad choices: megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

It's London Screenings week and the start of a new chapter as Mip comes to London, so who better to chat to this week than industry legend Dermot Horan, Director of Acquisitions and Co-productions at RTE. We talked about the importance of co-productions to the drama landscape, what makes a good buyer and salesperson, how best to navigate international events like the London Screenings and the three executives he would bring for company if he ended up Lost. Enjoy!You can find Here Comes Pod on Apple Podcasts, Spotify, Amazon or most other podcast outlets. If you enjoyed this episode of Here Comes Pod please do leave a review on Apple Podcasts, Spotify or wherever you listen to your podcasts

In this edition of the AppleVis Extra, David Nason speaks to Karthik Kannan, co-founder of Envision Technologies, winner of the inaugural AppleVis David Goodwin Award. This award recognises developers who have excelled in providing great apps and experiences for the blind and low vision community over a sustained period of time. They discuss the background of the company, key milestones, and the exciting Ally app which is due to launch soon.TranscriptDisclaimer: This transcript was generated by Aiko, an AI-powered transcription app. It is not edited or formatted, and it may not accurately capture the speakers' names, voices, or content.Hello there and welcome to another episode of the AppleVis this extra podcast this is episode one hundred and five my name is david nason.Today we are talking about the AppleVis end of twenty twenty four awards again but this is a particular special one today because it's the inaugural david goodwin award david as you most likely know.Founded AppleVisway back in twenty ten and after fourteen years of real dedication he stepped away in the middle of last year.Thankfully we have been able to go on and it's really fitting that this award in particular has been named in david's honor.The david goodwin award rewards a developer who has shown a lasting and enduring dedication to the community with significant apps and really made an impact and they need to have been.Active with an at least one app for over three years and our winner has been many more years than that and so it's a really special awards and we're delighted to have started up this year and really excited to talk to the winner.Today before I get into that conversation I will give a quick overview of the nominees we had a lot of nominees for this award and which is a great sign in of itself really.Nineteen nominated on the panel so let us have a quick run through just to get that acknowledgement to those nominees we had a sharp LLC who make king of dragon pass.We had american printing house for the blind to make good maps at doors agile tortoise who make drafts era tech corporation who make era explorer cash reader sro who make that cash reader app dolphin computer access limited to of course make dolphin easy reader.Envision technologies bv who make the envision app flexi bits incorporated who make the fantastical calendar app junew quang who makes.Mona for mastodon and also spring for twitter canoe suit who makes the leer rss feeder app library of congress who make bird mobile.MIP soft who makes the blind square up national federation the blind to make nfp newsline oreo gomez makes round logic and accessible hangman accessible twenty forty eight and many more great games that we enjoy.Sneaky crab incorporated who make time crest twisted wave limited to make the twisted weight audio app.Ulysses gmbh to make the ulysses writing app and weather god's LLC who make of course the weather gods weather app a very popular app over the years as well.And finally would you juice limited to make hockey side and fright recording apps so big list congratulations to everybody who was nominated it's.Great to see so many developers who have shown that long term dedication to making great apps for our community.So the runners up…

Der norwegische Mathematiker Niels Henrik Abel macht Anfang des 19. Jahrhunderts wichtige mathematische Entdeckungen. Doch erst nach seinem Tod wird ihm die Anerkennung zuteil, die er verdient. Die Idee für diesen Podcast hat Demian Nahuel Goos am MIP.labor entwickelt, der Ideenwerkstatt für Wissenschaftsjournalismus zu Mathematik, Informatik und Physik an der Freien Universität Berlin, ermöglicht durch die Klaus Tschira Stiftung. (00:00:02) Einleitung (00:02:19) Aufwachsen zwischen den Fronten (00:06:59) Abels mathematische Erweckung (00:09:16) Unterstützung für das ungewöhnliche Talent (00:13:09) Die ernüchternde Europa-Reise (00:16:37) Vom Pech verfolgt (00:20:59) Begründung der Gruppentheorie (00:24:31) Katalogisierung des Symmetriegruppen-Zoos (00:28:04) Die Monster-Gruppe (00:30:59) Fazit & Verabschiedung >> Artikel zum Nachlesen: https://detektor.fm/wissen/geschichten-aus-der-mathematik-niels-henrik-abel

WHAT A WEEK FOR WOMEN'S BASKETBALL! We're covering everything from WNBA shakeups to Unrivaled face-offs including: Lisa Leslie's disappearance from the boom boom room! BG's new BFFs! Plus: Our way-too-early 2025 MIP selections! #NewYorkLiberty #LasVegasAces #SeattleStorm #IndianaFever #ConnecticutSun #PhoenixMercury #DallasWings #ChicagoSky #MinnesotaLynx #WashingtonMystics #LosAngelesSparks #AtlantaDream #TorontoTempo #GoldenStateValkyries #WNBADraft #Unrivaled #skylardigginssmith #SabrinaIonescu #katemartin #angelreese

Thu, 23 Jan 2025 05:30:00 +0000 https://sleeperpod.podigee.io/50-new-episode 72b01b711ce8411d91d792fbd6c0a5f5 Your fantasy basketball waiver wire, sometimes it's bursting, sometimes bare. Stop reading this and go pick up Kel'el Ware! The wire is loaded with intrigue at the moment, not time to pick up the Tim Hardaways of the world. Let the boys take you through the names - both to pick up and safe drops to match - and make the most of those transactions this week! Pod Corrections - Min 48 - Cade for MIP, not MVP! Min 12 - Suns sent three 2nd rd picks out for Nick Richards, not three 1st rd picks. PTJ is an independent Fantasy Basketball Podcast that dives deep into the margins. A pod for the people - for fantasy hoop heads by fantasy heads! If you like what you hear, please kindlyRATE/REVIEW/SHARE/SUBSCRIBE Follow PTJ on Twitter @projthejumpod & Flyin' J himself @Quanophysics Love organic fair trade coffee & vintage NBA trading cards? So do we! Check out our partnership with Steel Bridge Coffee! https://www.steelbridgecoffee.com/ptj.html You already know the takes shall remain scorching hot. "Natron Clean" IS Nathan Litke. "Flyin' J" IS Jamie Macquarrie. fantasybasketballadvice #waiverwire #basketballpodcast #kelelware #isaiahcollier #keonellis #nicksmithjr #casonwallace #utahjazz #phoenixsuns #danielgafford #ludort #spencerdinwiddie full no Flying J Natron Clean

The nerds give out their NBA Midseason Awards, debating whether Shai Gilgeous-Alexander or Nikola Jokic should be the MVP frontrunner, if Victor Wembanyama or Evan Mobley should be DPOY, and who makes the strongest MIP case in a loaded race. Timestamps 00:00:23 - MVP 00:15:23 - Oklahoma City 00:25:40 - DPOY 00:31:30 - ROY 00:41:44 - MIP 00:54:58 - 6MOY 01:01:09 - COY #VolumeSee omnystudio.com/listener for privacy information.

[This interview was conducted online and there may be some audio variation.] "Writing has extracted from me this idea of exorcising demons, but also exercising a self that felt so erased." -Cherry Lou Sy In the first MiP episode of 2025, Jenn speaks with debut author Cherry Lou Sy (Love Can't Feed You) about adjusting to prose writing as a playwright, the line between fiction and autofiction, and how the stories we need to create most come from a necessity to be seen.  [You can sign up for the MiP monthly newsletter with job listings, guest news, transcripts, and new eps on the MiP website here. A transcript of this episode is available.] This month's episode & newsletter were sponsored by Writeability, a nonprofit writers guild, in defense of the imagination. Intro/Outro music is by Moutaineer and licensed through Premuim Beat.

21 games into the season, Alex and Facci deep dive into everything that has happened so far this season: Vibes and feelings on the team so far Biggest takeaways from this year compared to last year Diving into the stats from last season to this year and comparing where the team ranks across the league Numbers of Games missed to injuries Standings currently Strength of Schedule so far and remaining strength of schedule Tyrese Haliburton's home and road splits Wins against teams above .500 this season Losses against teams below .500 this season Should the Pacers look to make any trades this season? If yes, who? Trade rumors from Mike Scotto of Hoops Hype How hot should Carlisle's seat be? Quarter Awards: MVP, MIP, DPOY, 6MOY, Hustle, Most Disappointing, Most Frustrating Final Thoughts Learn more about your ad choices. Visit podcastchoices.com/adchoices